Company intelligence / Profile preview
Worg Pharmaceuticals
- Ownership
- Private
- Employees
- ~100
- Development stage
- Phase 3
Overview
Worg Pharmaceuticals is a clinical-stage biopharmaceutical company specializing in innovative immunotherapies for allergies and autoimmune diseases. Its pipeline includes over 20 products spanning preclinical to Phase 2 trials. The Apitope platform has demonstrated success in phase II trials for multiple sclerosis and Graves' disease. The company has expanded its portfolio through acquisitions of Apitope’s platform and Biomay’s PCFiT technology.[1][2]
- Therapeutic areas
- Immunology
- Modalities
- Synthetic peptides (apitopes)Therapeutic vaccinesFusion proteinsCombination vaccines[6]
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Worg Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Worg Pharmaceuticals.